ArticleGels (Basel, Switzerland)2022
Synthesis and Weak Hydrogelling Properties of a Salt Resistance Copolymer Based on Fumaric Acid Sludge and Its Application in Oil Well Drilling Fluids.
Article in Gels (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 11 citations in OpenAlex.
- Effect of Sodium Acetate on High-Temperature Gelation Characteristics of Sodium-Modified Calcium-Based Bentonite Water-Based Drilling Fluids.Gels (Basel, Switzerland) · 2026Article
- Composition, Properties, and Utilization of Fumaric Acid Sludge By-Produced from Industrial Phthalic Anhydride Wastewater Treatment.Polymers · 2022Article
- Formation-Damage Mechanism and Gel-Breaker-Free Drill-In Fluid for Carbonate Reservoir.Gels (Basel, Switzerland) · 2022Article
- Editorial on Special Issue "Gels for Oil and Gas Industry Applications".Gels (Basel, Switzerland) · 2022Article
- Novel Acrylamide/2-Acrylamide-2-3 Methylpropanesulfonic Acid/Styrene/Maleic Anhydride Polymer-Based CaCOGels (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fumaric acid sludge (FAS) by-produced from phthalic anhydride production wastewater treatment contains a large amount of refractory organic compounds with a complex composition, which will cause environmental pollution unless it is treated in a deep, harmless manner. FAS included saturated carboxylic acid, more than 60%, and unsaturated carboxylic acid, close to 30%, which accounted for the total mass of dry sludge. A new oil well drilling fluid filtrate loss reducer, poly(AM-AMPS-FAS) (PAAF), was synthesized by copolymerizing FAS with acrylamide (AM) and 2-acrylamide-2-methyl propane sulfonic acid (AMPS). Without a refining requirement for FAS, it can be used as a polymerizable free radical monomer for the synthesis of PAAF after a simple drying process. The copolymer PAAF synthesis process was studied, and the optimal monomer mass ratio was determined to be AM:AMPS:FAS = 1:1:1. The temperature resistance of the synthesized PAAF was significantly improved when 5% sodium silicate was added as a cross-linking agent. The structural characterization and evaluation of temperature and complex saline resistance performance of PAAF were carried out. The FT-IR results show that the structure of PAAF contained amide groups and sulfonic acid groups. The TGA results show that PAAF has good temperature resistance. As an oilfield filtrate loss reducer, the cost-effective copolymer PAAF not only has excellent temperature and complex saline resistance, the API filtration loss (FL) was only 13.2 mL/30 min after 16 h of hot rolling and aging at 150 °C in the complex saline-based mud, which is smaller compared with other filtrate loss reducer copolymers, but it also has little effect on the rheological properties of drilling fluid.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.